Abstract
The onset of brain diseases has a terrible impact on people’s lives, including brain tumors, Alzheimer’s disease, Parkinson’s disease, depression, and schizophrenia. Thus, the diagnosis and treatment of various brain disorders have been receiving specific attention. The fluorescence imaging technique is useful for examining brain diseases because it is intuitive, in situ, and real-time. Therefore, fluorescent imaging has so far been successfully employed to identify molecules associated with brain disease. In this review, the last five years of research advancements in fluorescent imaging agents for the above diseases are summarized, and the creation of pertinent fluorescence probes is described and prospected.
Cite
CITATION STYLE
Che, F., Zhao, X., Wang, X., Li, P., & Tang, B. (2023). Fluorescent Imaging Agents for Brain Diseases. Targets, 1(1), 5–33. https://doi.org/10.3390/targets1010003
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.